HRP20060401A2 - Piperazine derivatives of alkyl oxindoles - Google Patents
Piperazine derivatives of alkyl oxindolesInfo
- Publication number
- HRP20060401A2 HRP20060401A2 HR20060401A HRP20060401A HRP20060401A2 HR P20060401 A2 HRP20060401 A2 HR P20060401A2 HR 20060401 A HR20060401 A HR 20060401A HR P20060401 A HRP20060401 A HR P20060401A HR P20060401 A2 HRP20060401 A2 HR P20060401A2
- Authority
- HR
- Croatia
- Prior art keywords
- piperazine derivatives
- oxindoles
- alkyl
- alkyl oxindoles
- derivatives
- Prior art date
Links
- 150000005623 oxindoles Chemical class 0.000 title 1
- 150000004885 piperazines Chemical class 0.000 title 1
- 229940066771 systemic antihistamines piperazine derivative Drugs 0.000 title 1
- 210000000748 cardiovascular system Anatomy 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000005625 indol-2-ones Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0400954A HU0400954D0 (en) | 2004-05-11 | 2004-05-11 | Piperazine derivatives of alkyl oxindoles |
| HU0500461A HUP0500461A3 (en) | 2005-05-05 | 2005-05-05 | Pyperazine derivatives of alkyl-oxindoles |
| PCT/HU2005/000048 WO2005108363A1 (en) | 2004-05-11 | 2005-05-10 | Piperazine derivatives of alkyl oxindoles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20060401A2 true HRP20060401A2 (en) | 2007-03-31 |
Family
ID=89985994
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20060401A HRP20060401A2 (en) | 2004-05-11 | 2006-11-20 | Piperazine derivatives of alkyl oxindoles |
| HR20090054T HRP20090054T3 (en) | 2004-05-11 | 2009-01-29 | Piperazine derivatives of alkyl oxindoles |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20090054T HRP20090054T3 (en) | 2004-05-11 | 2009-01-29 | Piperazine derivatives of alkyl oxindoles |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20070219209A1 (xx) |
| EP (1) | EP1751106B1 (xx) |
| JP (1) | JP2007537226A (xx) |
| KR (1) | KR20070011551A (xx) |
| AT (1) | ATE412634T1 (xx) |
| AU (1) | AU2005240842B2 (xx) |
| BG (1) | BG109768A (xx) |
| CA (1) | CA2564009A1 (xx) |
| CZ (1) | CZ2006778A3 (xx) |
| DE (1) | DE602005010694D1 (xx) |
| DK (1) | DK1751106T3 (xx) |
| EA (1) | EA011280B1 (xx) |
| ES (1) | ES2317241T3 (xx) |
| HR (2) | HRP20060401A2 (xx) |
| IL (1) | IL178759A0 (xx) |
| MX (1) | MXPA06013064A (xx) |
| NO (1) | NO20065697L (xx) |
| NZ (1) | NZ551542A (xx) |
| PL (1) | PL1751106T3 (xx) |
| PT (1) | PT1751106E (xx) |
| RS (1) | RS20060620A (xx) |
| SI (1) | SI1751106T1 (xx) |
| SK (1) | SK51112006A3 (xx) |
| WO (1) | WO2005108363A1 (xx) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007537229A (ja) * | 2004-05-11 | 2007-12-20 | エギシュ ヂョヂセルヂャール エンニュ・エル・テー | ジアルキルオキシインドールの新規なピペラジン誘導体 |
| US10316025B2 (en) | 2015-06-03 | 2019-06-11 | Sunshine Lake Pharma Co., Ltd. | Substituted piperazine compounds and methods of use and use thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4452808A (en) * | 1982-12-07 | 1984-06-05 | Smithkline Beckman Corporation | 4-Aminoalkyl-2(3H)-indolones |
| MX173362B (es) * | 1987-03-02 | 1994-02-23 | Pfizer | Compuestos de piperazinil heterociclicos y procedimiento para su preparacion |
| FR2635104B1 (fr) * | 1988-08-03 | 1992-04-30 | Synthelabo | Derives d'indolone, leur preparation et leur application en therapeutique |
| GB8830312D0 (en) * | 1988-12-28 | 1989-02-22 | Lundbeck & Co As H | Heterocyclic compounds |
| WO1998008816A1 (fr) * | 1996-08-26 | 1998-03-05 | Meiji Seika Kaisha, Ltd. | Derives d'indoxyle et psychotropes |
-
2005
- 2005-05-10 AT AT05745442T patent/ATE412634T1/de active
- 2005-05-10 WO PCT/HU2005/000048 patent/WO2005108363A1/en active Application Filing
- 2005-05-10 EP EP05745442A patent/EP1751106B1/en active Active
- 2005-05-10 KR KR1020067025135A patent/KR20070011551A/ko not_active Application Discontinuation
- 2005-05-10 SK SK5111-2006A patent/SK51112006A3/sk not_active Application Discontinuation
- 2005-05-10 DE DE602005010694T patent/DE602005010694D1/de active Active
- 2005-05-10 JP JP2007512356A patent/JP2007537226A/ja active Pending
- 2005-05-10 CA CA002564009A patent/CA2564009A1/en not_active Abandoned
- 2005-05-10 NZ NZ551542A patent/NZ551542A/en unknown
- 2005-05-10 MX MXPA06013064A patent/MXPA06013064A/es active IP Right Grant
- 2005-05-10 PL PL05745442T patent/PL1751106T3/pl unknown
- 2005-05-10 SI SI200530563T patent/SI1751106T1/sl unknown
- 2005-05-10 PT PT05745442T patent/PT1751106E/pt unknown
- 2005-05-10 CZ CZ20060778A patent/CZ2006778A3/cs unknown
- 2005-05-10 RS RSP-2006/0620A patent/RS20060620A/sr unknown
- 2005-05-10 ES ES05745442T patent/ES2317241T3/es active Active
- 2005-05-10 US US11/596,466 patent/US20070219209A1/en not_active Abandoned
- 2005-05-10 EA EA200602080A patent/EA011280B1/ru not_active IP Right Cessation
- 2005-05-10 AU AU2005240842A patent/AU2005240842B2/en not_active Ceased
- 2005-05-10 DK DK05745442T patent/DK1751106T3/da active
-
2006
- 2006-10-19 IL IL178759A patent/IL178759A0/en unknown
- 2006-11-20 HR HR20060401A patent/HRP20060401A2/xx not_active Application Discontinuation
- 2006-12-11 BG BG109768A patent/BG109768A/bg unknown
- 2006-12-11 NO NO20065697A patent/NO20065697L/no not_active Application Discontinuation
-
2009
- 2009-01-29 HR HR20090054T patent/HRP20090054T3/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2317241T3 (es) | 2009-04-16 |
| PT1751106E (pt) | 2009-02-10 |
| MXPA06013064A (es) | 2007-04-27 |
| ATE412634T1 (de) | 2008-11-15 |
| US20070219209A1 (en) | 2007-09-20 |
| EA011280B1 (ru) | 2009-02-27 |
| DE602005010694D1 (de) | 2008-12-11 |
| KR20070011551A (ko) | 2007-01-24 |
| SI1751106T1 (sl) | 2009-06-30 |
| PL1751106T3 (pl) | 2009-07-31 |
| EP1751106A1 (en) | 2007-02-14 |
| EA200602080A1 (ru) | 2007-04-27 |
| DK1751106T3 (da) | 2009-03-09 |
| SK51112006A3 (sk) | 2007-05-03 |
| AU2005240842A1 (en) | 2005-11-17 |
| BG109768A (bg) | 2008-03-31 |
| JP2007537226A (ja) | 2007-12-20 |
| NZ551542A (en) | 2010-06-25 |
| IL178759A0 (en) | 2007-02-11 |
| EP1751106B1 (en) | 2008-10-29 |
| CZ2006778A3 (cs) | 2007-03-07 |
| CA2564009A1 (en) | 2005-11-17 |
| RS20060620A (xx) | 2008-09-29 |
| HRP20090054T3 (en) | 2009-03-31 |
| AU2005240842B2 (en) | 2011-10-06 |
| WO2005108363A1 (en) | 2005-11-17 |
| NO20065697L (no) | 2007-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE0303180D0 (sv) | Novel compounds | |
| SE0302232D0 (sv) | Novel Compounds | |
| SE0201635D0 (sv) | Novel compounds | |
| EA201100749A1 (ru) | Производные пиридина и пиримидина в качестве ингибиторов фосфодиэстеразы 10 | |
| CY1112914T1 (el) | Υποκατεστημενα παραγωγα ινδολυλ αλκυλ αμινης ως νεοι αναστολεις των αποακετυλασων ιστονης | |
| MA30076B1 (fr) | Carbonylaminopyrrolopyrazoles servant de puissants inhibiteurs de kinases. | |
| EA201100311A1 (ru) | Амидные производные гетероарилов и их применение в качестве активаторов глюкокиназы | |
| ATE429427T1 (de) | Pyrimidinderivate als orexin-rezeptorantagonisten | |
| TW200728258A (en) | Novel compounds | |
| HRP20050533A2 (en) | Aminoindazole derivatives and use thereof as kinase inhibitors | |
| CY1109854T1 (el) | Παραγωγα αζαδικυκλο(3.1.0)εξανιου χρησιμα ως ρυθμιστες υποδοχεων d3 ντοπαμινης | |
| EA200701930A1 (ru) | Производные пиримидина для лечения гиперпролиферативных нарушений | |
| NO20076371L (no) | Fremgangsmate for fremstilling av fenoliske 4-bifenylylazetidin-2-oner | |
| NO20075406L (no) | Pyrimidindionerivater som prokineticin-2-reseprorantagonister | |
| BRPI0518203A2 (pt) | mÉtodos para preparaÇço de compostos indazol | |
| EA201001481A1 (ru) | Производные третичного амина в качестве ингибиторов фосфодиэстеразы-4 | |
| DE60214990D1 (de) | Benzolsulfonsäureester-indol-5-yl als 5-ht6 rezeptor-antagonisten | |
| EA201070804A1 (ru) | (аза)индольное производное, замещенное по положению 5, содержащая его фармацевтическая композиция, промежуточные соединения и способ их получения | |
| ATE542796T1 (de) | N-sulfonylcarboximidamidverbindungen als apoptosepromotoren | |
| EA201000675A1 (ru) | Производные хромана как модуляторы trpv3 | |
| EA200801549A1 (ru) | Новые производные фенантридина в качестве антагонистов брадикинина | |
| ATE502945T1 (de) | Ä ä5- ( phenyl) - 6- phenylpyrrolo ä2,1-füä2,1, 4ütriazin-4-ylüaminoü carbonsäurederivate und verwandte verbindungen als prostazyklin (pgi2) ip-rezeptor aktivatoren zur behandlung von kardiovaskulären erkrankungen | |
| HRP20060402A2 (en) | Pyridine derivatives of alkyl oxindoles as 5-ht7 receptor active agents | |
| HRP20060401A2 (en) | Piperazine derivatives of alkyl oxindoles | |
| HRP20060420A2 (en) | Piperazine derivatives of alkyl oxindoles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| AIPI | Request for the grant of a patent on the basis of a substantive examination of a patent application | ||
| ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20100419 Year of fee payment: 6 |
|
| OBST | Application withdrawn |